These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11073160)

  • 21. A single clone of Acinetobacter baumannii, ST22, is responsible for high antimicrobial resistance rates of Acinetobacter spp. isolates that cause bacteremia and urinary tract infections in Korea.
    Park YK; Lee GH; Baek JY; Chung DR; Peck KR; Song JH; Ko KS
    Microb Drug Resist; 2010 Jun; 16(2):143-9. PubMed ID: 20370437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico.
    Rosales-Reyes R; Gayosso-Vázquez C; Fernández-Vázquez JL; Jarillo-Quijada MD; Rivera-Benítez C; Santos-Preciado JI; Alcántar-Curiel MD
    PLoS One; 2017; 12(8):e0182899. PubMed ID: 28797068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bismuth subsalicylate increases intracellular Ca2+, MAP-kinase activity, and cell proliferation in normal human gastric mucous epithelial cells.
    Gilster J; Bacon K; Marlink K; Sheppard B; Deveney C; Rutten M
    Dig Dis Sci; 2004 Mar; 49(3):370-8. PubMed ID: 15139483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts.
    Manhart MD
    Rev Infect Dis; 1990; 12 Suppl 1():S11-5. PubMed ID: 2406851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular typing of Acinetobacter baumannii-Acinetobacter calcoaceticus complex isolates from endemic and epidemic nosocomial infections.
    Ratto P; Sordelli DO; Abeleira E; Torrero M; Catalano M
    Epidemiol Infect; 1995 Feb; 114(1):123-32. PubMed ID: 7867730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Thomas VM; Brown RM; Ashcraft DS; Pankey GA
    Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of bismuth subsalicylate on fecal microflora.
    Gorbach SL; Cornick NA; Silva M
    Rev Infect Dis; 1990; 12 Suppl 1():S21-3. PubMed ID: 2305174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complexity of Complement Resistance Factors Expressed by
    Sanchez-Larrayoz AF; Elhosseiny NM; Chevrette MG; Fu Y; Giunta P; Spallanzani RG; Ravi K; Pier GB; Lory S; Maira-Litrán T
    J Immunol; 2017 Oct; 199(8):2803-2814. PubMed ID: 28855313
    [No Abstract]   [Full Text] [Related]  

  • 29. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of successive Acinetobacter baumannii isolates from a deceased haemophagocytic lymphohistiocytosis patient.
    Choi HJ; Kil MC; Choi JY; Kim SJ; Park KS; Kim YJ; Ko KS
    Int J Antimicrob Agents; 2017 Jan; 49(1):102-106. PubMed ID: 27842758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.
    Russo TA; Luke NR; Beanan JM; Olson R; Sauberan SL; MacDonald U; Schultz LW; Umland TC; Campagnari AA
    Infect Immun; 2010 Sep; 78(9):3993-4000. PubMed ID: 20643860
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Dahdouh E; Hajjar M; Suarez M; Daoud Z
    Front Cell Infect Microbiol; 2016; 6():163. PubMed ID: 27933276
    [No Abstract]   [Full Text] [Related]  

  • 33. Behaviour of Acinetobacter strains with normal human serum.
    Cervi BM; Monetto AM
    Cent Eur J Public Health; 1996 Sep; 4(3):197-200. PubMed ID: 8884057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding and killing of bacteria by bismuth subsalicylate.
    Sox TE; Olson CA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2075-82. PubMed ID: 2694949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications.
    Vega-Jiménez AL; Almaguer-Flores A; Flores-Castañeda M; Camps E; Uribe-Ramírez M; Aztatzi-Aguilar OG; De Vizcaya-Ruiz A
    Nanotechnology; 2017 Oct; 28(43):435101. PubMed ID: 28837052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids.
    Patwardhan RB; Dhakephalkar PK; Niphadkar KB; Chopade BA
    Indian J Med Res; 2008 Aug; 128(2):178-87. PubMed ID: 19001682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile.
    Mahony DE; Woods A; Eelman MD; Burford N; Veldhuyzen van Zanten SJ
    Antimicrob Agents Chemother; 2005 Jan; 49(1):431-3. PubMed ID: 15616328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Surface characteristics and antimicrobial sensitivity of clinical strains of Acinetobacter spp].
    Martínez MA; Pinto ME; Zemelman R; Cifras LA; Lira G; Ramírez C
    Rev Med Chil; 1998 Sep; 126(9):1079-84. PubMed ID: 9922511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sensitivity to blood bactericidal activity and hydrophobicity of Acinetobacter baumannii after treatment with imipenem].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1999 Apr; 48(2):67-70. PubMed ID: 10349782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.
    Lee HW; Koh YM; Kim J; Lee JC; Lee YC; Seol SY; Cho DT; Kim J
    Clin Microbiol Infect; 2008 Jan; 14(1):49-54. PubMed ID: 18005176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.